☆ 4.5 Article

EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia

Translational Oncology (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer

Esther Visser et al.

Summary: This study establishes the diagnostic value of ctDNA-ddPCR analysis and suggests that combining ctDNA-ddPCR with tDNA-NGS only when ctDNA-ddPCR is negative can increase the number of mutations detected and reduce the need for (additional) biopsies.

TRANSLATIONAL ONCOLOGY (2023)

添加到收藏夹

Article Oncology

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

A. Passaro et al.

Summary: The European Society for Medical Oncology (ESMO) conducted a virtual consensus-building process in 2021 to discuss the management of EGFR-mutant non-small-cell lung cancer. The experts developed recommendations on various topics, including tissue and biomarkers analyses, early and locally advanced disease, metastatic disease, clinical trial design, patient's perspective, and miscellaneous.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Biochemical Research Methods

Malignant pleural effusions for cancer genotyping: A matter of trans-pleural traffic of cell-free tumor DNA

Gabor Mehes et al.

Summary: Fluid accumulating in progressive malignancies can be tested for cancer-related features, with the cell-free DNA fraction reflecting molecular characteristics of the tumor process. Pleural effusions can be used for genetic profiling in lung cancer, with the concentration of cfDNA depending on various factors in benign and malignant conditions. The enrichment of effusion tumor DNA may be influenced by factors such as pleural metastasis, tumor angiogenesis, and inflammatory processes.

MOLECULAR AND CELLULAR PROBES (2022)

添加到收藏夹

Article Oncology

Cytology-Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non-Small Cell Lung Cancer

Chi-Lu Chiang et al.

Summary: This study investigates the optimal approach for EGFR mutation testing in NSCLC patients using centrifuged effusion samples and proposes a cytology-based specimen triage. The proposed strategy improves the detection rate of EGFR mutations and provides an efficient testing strategy for patients with EGFR-mutant NSCLC.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report

Anna Kerpel-Fronius et al.

Summary: The feasibility and effectiveness of lung cancer screening for individuals who never smoked are uncertain due to current screening guidelines typically excluding this group. Evaluation in each country considering various factors, including risk assessment accuracy and cost-effectiveness, is necessary. Current evidence supporting widespread implementation of screening for never smokers is lacking.

JOURNAL OF THORACIC ONCOLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

Jinghua He et al.

Summary: This real-world study provides comprehensive insights into the testing and treatment patterns for patients with EGFR mutations in non-small cell lung cancer. Despite recent improvements, increased utilization of EGFR testing, including advanced methods, is necessary to optimize treatment pathways and outcomes.

ADVANCES IN THERAPY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma

Vera Jokic et al.

Summary: This study evaluated the clinical and low-cost genetic determinants of treatment outcomes in EGFR mutation positive advanced lung adenocarcinoma patients. The findings showed that genetic factors had a significant impact on the response to TKI therapy, leading to pain alleviation.

DOSE-RESPONSE (2022)

添加到收藏夹

Editorial Material Oncology

Lung Cancer in Serbia

Milena Cavic et al.

JOURNAL OF THORACIC ONCOLOGY (2022)

添加到收藏夹

Article Health Care Sciences & Services

Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience

Michelle Chen et al.

Summary: We describe our institutional experience of developing a liquid biopsy approach using circulating tumor DNA (ctDNA) analysis for personalized medicine in cancer patients. The study focuses on the hurdles encountered during the process and provides insights for other investigators. Through sequencing tumor DNA and circulating cell-free DNA, our study shows that driver mutations can be detected in ctDNA, providing guidance for personalized treatment and monitoring tumor burden in cancer patients.

JOURNAL OF PERSONALIZED MEDICINE (2022)

添加到收藏夹

Article Oncology

EGFR testing in paraffin-embedded cell block cytology material is reliable with increased detection for effusion fluid

Joanna Ka Man Ng et al.

Summary: In this study, a large cohort of EGFR tests was reviewed to evaluate the adequacy, detection rate, and discrepancy rate of cytology material. The results indicate that cytology material has lower adequacy rates, while pleural fluid is superior to pleural biopsies for molecular testing.

LUNG CANCER (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

Jelena Spasic et al.

Summary: This study identified a set of easily determined genetic and clinical predictors that can be used to predict survival rates and specific toxicity profiles of platinum-based chemotherapy in advanced lung adenocarcinoma.

DOSE-RESPONSE (2022)

添加到收藏夹

Review Respiratory System

Cytologic Investigations for the Diagnosis of Malignant Pleural Effusion in Non-small Cell Lung Cancer State-of-the-art Review for Pulmonologists

Samira Shojaee et al.

Summary: Lung cancer is the leading cause of cancer-related deaths globally, with malignant pleural effusion indicating an advanced stage and poor prognosis. Pleural fluid cytology plays a crucial role in non-small cell lung cancer patients, aiding in diagnosis and treatment decisions.

JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY (2021)

添加到收藏夹

Article Pathology

Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals

Milena Cavic et al.

Summary: The SARS-CoV-2 pandemic had a profound negative impact on the diagnostic output of Serbia's largest molecular diagnostics center for cancer patients and high-risk individuals, but it also resulted in shorter waiting lists for hereditary cancer patients and high-risk individuals.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)

添加到收藏夹

Article Oncology

Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity

Vera Jokic et al.

Summary: This study indicates that the low baseline value of the hematological parameter NMR may serve as a predictor of survival in EGFR-TKI-treated NSCLC patients. Additionally, the values of NLR and LMR are associated with the occurrence of adverse reactions in patients.

EXPERT REVIEW OF ANTICANCER THERAPY (2021)

添加到收藏夹

Article Oncology

Cell-free DNA From Pleural Effusion Samples: Is It Right for Molecular Testing in Lung Adenocarcinoma?

Attila Mokanszki et al.

Summary: The study revealed that cfDNA isolated from pleural effusion showed significantly higher yield compared to that from PB, and gene mutations could be safely demonstrated from the effusion cfDNA fraction. Pleural effusion appears to be a particularly suitable source for serial genotyping of pulmonary adenocarcinoma.

PATHOLOGY & ONCOLOGY RESEARCH (2021)

添加到收藏夹

Article Medicine, General & Internal

Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing

Yongfeng Yu et al.

Summary: Cell-free DNA (cfDNA) from pleural effusion supernatant shows potential as a surrogate sample for detecting therapeutic targets and tumor mutation burden in advanced NSCLC patients. It is suggested that direct use of total cfDNA without fragmentation for library preparation in clinical practice may yield more accurate genetic testing results, avoiding interference from long fragments of cfDNA.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)

添加到收藏夹

Article Oncology

A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer

Shidai Jin et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2020)

添加到收藏夹

Article Medicine, General & Internal

Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR

Annamaria Siggillino et al.

DIAGNOSTICS (2020)

添加到收藏夹

Article Oncology

Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis

Akihiro Yoshimura et al.

THORACIC CANCER (2019)

添加到收藏夹

Article Oncology

Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions

Sergio Villatoro et al.

MOLECULAR ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma

Ping Zhang et al.

THORACIC CANCER (2019)

添加到收藏夹

Article Pathology

TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool

Milena Cavic et al.

JOURNAL OF CLINICAL PATHOLOGY (2019)

添加到收藏夹

Article Respiratory System

Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens

Liping Liu et al.

JOURNAL OF THORACIC DISEASE (2018)

添加到收藏夹

Article Oncology

A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients

Qin Feng et al.

CANCER MANAGEMENT AND RESEARCH (2018)

添加到收藏夹

Article Oncology

EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study

Baohui Han et al.

LUNG CANCER (2017)

添加到收藏夹

Editorial Material Chemistry, Physical

Treasure trove for cancer medicine

Miljana Tanic et al.

NATURE MATERIALS (2017)

添加到收藏夹

Article Medicine, General & Internal

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer

T. S. Mok et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Medical Laboratory Technology

Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients

Saeam Shin et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)

添加到收藏夹

Article Oncology

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

James Chih-Hsin Yang et al.

LANCET ONCOLOGY (2015)

添加到收藏夹

Article Respiratory System

Clinical features and survival of lung cancer patients with pleural effusions

Jose M. Porcel et al.

RESPIROLOGY (2015)

添加到收藏夹

Letter Oncology

EGFR Mutations in Asian Patients with Advanced Lung Adenocarcinoma

Chong-Kin Liam et al.

JOURNAL OF THORACIC ONCOLOGY (2014)

添加到收藏夹

Article Pathology

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2013)

添加到收藏夹

Review Oncology

Liquid biopsy: monitoring cancer-genetics in the blood

Emily Crowley et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2013)

添加到收藏夹

Review Respiratory System

Pleural Effusion in Lung Cancer: More Questions than Answers

Marios E. Froudarakis

RESPIRATION (2012)

添加到收藏夹

Editorial Material Respiratory System

Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010

Clare Hooper et al.

THORAX (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.